Note: Ingredients listed on restricted chemical lists
EC/CAS
50-99-7
Name of the chemical
Glucose C6H12O6
Concentration
N/A
General Information
Revision date
2022-02-17
Product name
ZINACEF (CEFUROXIME INJECTION)
Product Synonyms
ZINACEF FROZEN PREMIX 750MG/50ML * ZINACEF FROZEN PREMIX 1.5G/50ML * ZINACEF
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
Tianjin SmithKline (GSK) Laboratory Co. Ltd.
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Emergency overview May cause an allergic skin reaction. Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Hazard statements
categories H317 May cause an allergic skin reaction.
Physical hazards
Not classified.
Health hazards
Sensitization, skin Category 1 See section 11 for additional information on health hazards.
Environmental hazards
Not classified. The product is not classified as environmentally hazardous. However, this does not exclude the possibility that large or frequent spills can have a harmful or damaging effect on the environment.
Signal word
Warning
Prevention
P261 Avoid breathing mist/vapours. P272 Contaminated work clothing should not be allowed out of the workplace. P280 Wear protective gloves.
Response
P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P321 Specific treatment (see instruction on this label). P333 + P313 If skin irritation or rash occurs: Get medical advice/attention. P362 + P364 Take off contaminated clothing and wash it before reuse.
Storage
None.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Other physicochemical hazards
The product is stable and non-reactive under normal conditions of use, storage and transport. No unusual fire or explosion hazards noted.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
2.55 % of the mixture consists of component(s) of unknown acute oral toxicity. 4.28 % of the mixture consists of component(s) of unknown acute dermal toxicity.
